SeekIn Inc is a biotech company founded in early 2018, focusing on blood-based pan cancer early detection utilizing next-generation sequencing and artificial intelligence. Since founded, SeekIn has been committed to providing cutting-edge and cost-effective solutions for cancer early detection, postoperative recurrence monitoring, and treatment response evaluation. SeekIn also developed novel molecular tests for leukemia patients. With its proprietary technical advances, SeekIn has launched a number of research and clinical studies in collaboration with top-tier hospitals in Japan, EU and China.
The management team of SeekIn consists of experts with insightful and complementary experiences in R&D, clinical lab management, business operations, corporate finance, and product commercialization.
In October 2020，Dr. Mao was invited to give a talk on TEDxTheBoud's annual meeting again (TEDxTheBund talk in 2018). As TED's vision is the power of ideas to change the world, his wish is to use early detection to control cancer, the emperor of all maladies.
I hope that with all our efforts today, when we identify a positive case, the person will say to me, "Dr. Mao, no worries. I just have cancer".
——— Mao Mao
Dr. Mao'sTEDxTheBund talk in 2020
multiplex, stepwise, cost-effective blood-based cancer screening
A NGS test to capture cancer genetic features in plasma
To calculate cancer risk score
Non-invasive blood based screening method,10ml blood